Epilepsy Research
Volume 30, Issue 1 , Pages 31-40 , March 1998

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

  • Reetta Kälviäinen

      Affiliations

    • Department of Neurology, University Hospital of Kuopio, Kuopio, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 17 173311; fax: +358 17 173031.
    • ,
  • Martin J Brodie

      Affiliations

    • Epilepsy Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK
    • ,
  • John Duncan

      Affiliations

    • Chalfont Centre for Epilepsy, Buckinghamshire, UK
    • ,
  • David Chadwick

      Affiliations

    • Department of Neurological Science, The Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool, UK
    • ,
  • David Edwards

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • Karsten Lyby

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • for the Northern European Tiagabine Study Group

Received 20 September 1997 ,Accepted 10 October 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00082-X

Epilepsy Research
Volume 30, Issue 1 , Pages 31-40 , March 1998

Article Tools

* Image Usage & Resolution